Key facts
- It has raised $2.4M; the latest was Later Stage VC ($2.4M) in Jan 2025.
- Notable investors include Suhail Sameer, Kunal Suri, OTP Venture.
- Status: Privately Held (backing).
Investors
3- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Zee Laboratories
- ·The full record, as it builds
Funding rounds
No funding rounds for Zee Laboratories are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zee Laboratories
Manufacturer of healthcare products intended to improve accessibility to essential medicines. The company is equipped with state-of-the-art manufacturing units and in-house testing capabilities, ensuring products meet global quality standards while catering to a wide range of therapeutic areas with an extensive distribution network and international presence, enabling government bodies, retail stores, and healthcare institutions across various regions to access affordable healthcare.
- Sector
- Healthcare
- HQ
- Delhi, India
- Founded
- 1994
- Employees
- 2,000
- Website
- zeelaboratories.com/
- Ownership
- Privately Held (backing)
Zee Laboratories doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zee Laboratories shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zee Laboratories in its N-PORT filings yet. We sweep new filings monthly.